- Home
- MLYS vs DJCO Comparison
MLYS vs DJCO Comparison
Compare MLYS & DJCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- DJCO
- Stock Information
- Founded
- MLYS 2019
- DJCO 1987
- Country
- MLYS United States
- DJCO United States
- Employees
- MLYS N/A
- DJCO N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- DJCO Newspapers/Magazines
- Sector
- MLYS Health Care
- DJCO Consumer Discretionary
- Exchange
- MLYS Nasdaq
- DJCO Nasdaq
- Market Cap
- MLYS 893.0M
- DJCO 793.7M
- IPO Year
- MLYS 2023
- DJCO N/A
- Fundamental
- Price
- MLYS $13.35
- DJCO $377.40
- Analyst Decision
- MLYS Strong Buy
- DJCO
- Analyst Count
- MLYS 3
- DJCO 0
- Target Price
- MLYS $33.00
- DJCO N/A
- AVG Volume (30 Days)
- MLYS 1.3M
- DJCO 9.3K
- Earning Date
- MLYS 05-08-2025
- DJCO 05-13-2025
- Dividend Yield
- MLYS N/A
- DJCO N/A
- EPS Growth
- MLYS N/A
- DJCO 370.42
- EPS
- MLYS N/A
- DJCO 55.48
- Revenue
- MLYS N/A
- DJCO $71,642,000.00
- Revenue This Year
- MLYS N/A
- DJCO N/A
- Revenue Next Year
- MLYS N/A
- DJCO N/A
- P/E Ratio
- MLYS N/A
- DJCO $6.80
- Revenue Growth
- MLYS N/A
- DJCO 0.34
- 52 Week Low
- MLYS $8.24
- DJCO $333.29
- 52 Week High
- MLYS $18.38
- DJCO $602.00
- Technical
- Relative Strength Index (RSI)
- MLYS 49.65
- DJCO 44.77
- Support Level
- MLYS $10.44
- DJCO $359.34
- Resistance Level
- MLYS $14.83
- DJCO $392.76
- Average True Range (ATR)
- MLYS 1.49
- DJCO 16.45
- MACD
- MLYS -0.14
- DJCO 0.32
- Stochastic Oscillator
- MLYS 43.24
- DJCO 31.99
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Journal Technologies segment.